miR-143-5p suppresses breast cancer progression by targeting the HIF-1α-related GLUT1 pathway

被引:18
作者
Xu, Jia [1 ]
Li, Xi [2 ]
Zhang, Purong [1 ]
Luo, Jie [1 ]
Mou, Exian [1 ]
Liu, Shiwei [1 ]
机构
[1] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Sch Med,Dept Breast Surg, 55,Sect 4,South Renmin Rd, Chengdu 610041, Sichuan, Peoples R China
[2] Chengdu First Peoples Hosp, Dept Plast Surg, Chengdu 610041, Sichuan, Peoples R China
关键词
breast cancer; microRNA-143-5p; hypoxia-inducible factor-1 alpha; glucose transporter 1; migration; RADIATION-THERAPY; GENE-EXPRESSION; GASTRIC-CANCER; MICRORNAS; METASTASIS; INVASION; IDENTIFICATION; STATISTICS; METABOLISM; PROGNOSIS;
D O I
10.3892/ol.2022.13268
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer (BC) is a commonly identified life-threatening type of cancer and a major cause of death among women worldwide. Several microRNAs (miRs), including miR-143-5p, have been reported to be vital for regulating hallmarks of cancer; however, the effect of miR-143-5p on BC requires further exploration. The present study performed bioinformatics analysis on GSE42072 and GSE41922 datasets from the National Center for Biotechnology Information Gene Expression Omnibus (GEO) database to identify miR-143-5p expression patterns. Furthermore, miR-143-5p expression was detected in BC cell lines and tissues via reverse transcription-quantitative PCR. Post-transfection with miR-143-5p mimics, Cell Counting Kit-8, colony formation and Transwell assays were performed to explore the effects of miR-143-5p on BC cell proliferation, colony formation, and migration. The association of miR-143-5p with the hypoxia-inducible factor-1 alpha (HIF-1 alpha)-associated glucose transporter 1 (GLUT1) pathway was explored via western blotting, immunofluorescence and dual-luciferase reporter assay. The present study detected high expression of miR-143-5p in BC tissue of the GSE42072 and serum of the GSE41922 datasets by GEO chip analysis. Additionally, the expression levels of miR-143-5p were decreased in BC tissues compared with those in adjacent healthy tissues, and low miR-143-5p expression was associated with a poorer prognosis and shorter survival time in patients with BC. In vitro, miR-143-5p expression levels were decreased in BC cells, and transfection with miR-143-5p mimics suppressed BC cell proliferation, colony formation, migration. Furthermore, miR-143-5p targeted the HIF-1 alpha-related GLUT1 pathway, and inhibited HIF-1 alpha and GLUT1 expression. Additionally, HIF-1 alpha agonists reversed the miR-143-5p-induced inhibition during tumorigenesis. In conclusion, miR-143-5p exhibited low expression in BC tissues, and suppressed BC cell proliferation, colony formation, migration. Moreover, the antitumor effects of miR-143-5p targeted the HIF-1 alpha-related GLUT1 pathway.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Dexmetomidine promotes the activity of breast cancer cells through miR-199a/HIF-1α axis
    Wen, Gang
    Xin, Naixing
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (11) : 4817 - 4828
  • [32] LncRNA-TCONS_00026907 is involved in the progression and prognosis of cervical cancer through inhibiting miR-143-5p
    Jin, Xuejing
    Chen, Xiangjian
    Hu, Yan
    Ying, Furong
    Zou, Ruanmin
    Lin, Feng
    Shi, Zhengzheng
    Zhu, Xuejie
    Yan, Xiaojian
    Li, Shi
    Zhu, Hua
    CANCER MEDICINE, 2017, 6 (06): : 1409 - 1423
  • [33] miR-7-5p suppresses cell proliferation and induces apoptosis of breast cancer cells mainly by targeting REGγ
    Shi, Yuan
    Luo, Xinrong
    Li, Peng
    Tan, Jinxiang
    Wang, Xiaoyi
    Xiang, Tingxiu
    Ren, Guosheng
    CANCER LETTERS, 2015, 358 (01) : 27 - 36
  • [34] miR-665 Suppresses the Epithelial-Mesenchymal Transition and Progression of Gastric Cancer by Targeting CRIM1
    Wu, Kun-Zhe
    Zhang, Chun-Dong
    Zhang, Cheng
    Pei, Jun-Peng
    Dai, Dong-Qiu
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3489 - 3501
  • [35] MiR-138-5p suppresses the progression of lung cancer by targeting SNIP1
    Wu, Jiaen
    Han, Xuejia
    Yang, Xiancong
    Li, Youjie
    Liang, Yan
    Sun, Guangbin
    Wang, Ranran
    Wang, Pingyu
    Xie, Shuyang
    Feng, Jiankai
    Sun, Hongfang
    THORACIC CANCER, 2023, 14 (06) : 612 - 623
  • [36] miR-410-3p suppresses breast cancer progression by targeting Snail
    Zhang, Ya-Feng
    Yu, Yue
    Song, Wang-Zhao
    Zhang, Rui-Ming
    Jin, Shan
    Bai, Jun-Wen
    Kang, Hong-Bin
    Wang, Xin
    Cao, Xu-Chen
    ONCOLOGY REPORTS, 2016, 36 (01) : 480 - 486
  • [37] miR-455-5p suppresses hepatocellular carcinoma cell growth and invasion via IGF-1R/AKT/GLUT1 pathway by targeting IGF-1R
    Hu, Yiren
    Yang, Zhangwei
    Bao, Dandan
    Ni, Jun-Sheng
    Lou, Jian
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (12)
  • [38] miR186 suppresses prostate cancer progression by targeting Twist1
    Zhao, Xian
    Wang, Yanli
    Deng, Rong
    Zhang, Hailong
    Dou, Jinzhuo
    Yuan, Haihua
    Hou, Guofang
    Du, Yuzhang
    Chen, Qin
    Yu, Jianxiu
    ONCOTARGET, 2016, 7 (22) : 33136 - 33151
  • [39] Targeting HIF-1α signaling pathway for gastric cancer treatment
    Li, Hongyu
    Jia, Yanfei
    Wang, Yunshan
    PHARMAZIE, 2019, 74 (01): : 3 - 7
  • [40] Long non-coding RNA LINC01207 silencing suppresses AGR2 expression to facilitate autophagy and apoptosis of pancreatic cancer cells by sponging miR-143-5p
    Liu, Chang
    Wang, Jin-Ou
    Zhou, Wen-Yang
    Chang, Xiao-Ying
    Zhang, Ming-Ming
    Zhang, Ying
    Yang, Xiang-Hong
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2019, 493